| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care 2009;2(Suppl 2): 55-58.
급성뇌경색에서 동맥내 혈전용해치료
연세대학교 의과대학 신경과학교실
Intra-Arterial Thrombolysis in Acute Ischemic Stroke
Hyo Suk Nam, MD
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
Early and complete recanalization of an occluded artery is the main therapeutic goal of acute ischemic stroke. Since the National Institute of Neurologic Disorders and Stroke (NINDS) study was done, intravenous (IV) recombinant tissue plasminogen activator (tPA) therapy within 3 hours after the onset of symptoms has been widely used. Despite the advantage of the rapid and easy initiation of thrombolytic therapy, IV tPA treatment is limited by low recanalization rates, particularly in cases of larger proximal arterial occlusions. Compared with the IV approach, intra-arterial (IA) thrombolysis is reported to have higher recanalization rates and an extended therapeutic window. However, IA thrombolysis is limited by the delay to the initiation of treatment and the need for specialized angiographic techniques. In this article, the previous IA thrombolytic therapy trial will be reviewed and the limitations and hope of IA thrombolytic therapy will be discussed.
Key Words: Thrombolytic therapy·Intra-arterial thrombolytic therapy·Acute ischemic stroke
Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810   FAX: +82-2-3672-7553    E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI